国产日韩一区二区三区在线观看,观看A一级一区二区三区精品视频,男人资源在线观看视频,午夜性色福利在线视频福利

    
    
  1. <ol id="3tx1v"><bdo id="3tx1v"><kbd id="3tx1v"></kbd></bdo></ol>
    <sup id="3tx1v"><thead id="3tx1v"><pre id="3tx1v"></pre></thead></sup>
  2. R&D Capability
    Home Innovation

    R&D Capability

    R&D Capability

    Remarkable R&D capabilities with over 20 years of R&D experience, Jiangsu Hansoh Pharma has several national-level R&D destinations, including the National Enterprise Technology Centers, Post-doctoral Research Station, and Key National Laboratory. The Company is highly efficient to discover innovative drugs, with R&D structure that covers areas such as peptides, biologics, small molecules, ADC drugs, and siRNAs.

    • 7
      launched innovative drugs
    • 40
      innovative drug candidates
    • 60 +
      clinical trials of innovative drug candidates being investigated
    • 60 +
      national scientific research projects such as 863 Program, Major Science and Technology Program for Innovation and Development of Significant New Drugs, and Torch Program
    • 2
      second prizes of National Science and Technology Progress Award
    • 2
      China Patent Gold Award
    • 600 +
      authorized invention patents at home and abroad
    • 200 +
      contributions to national standards
    R&D Team
    • 3
      State Council Special Allowance Experts
    • 16
      Jiangsu "innovative and entrepreneurial talent"
    • 9
      Jiangsu "333 talent project"
    • 1800 +
      R&D fellows in China and abroad